---
layout: default
title: Fleming-R1: Toward Expert-Level Medical Reasoning via Reinforcement Learning
---

# Fleming-R1: Toward Expert-Level Medical Reasoning via Reinforcement Learning

<div class="paper-toolbar">
  <a href="https://arxiv.org/abs/2509.15279" class="toolbar-btn" target="_blank">ğŸ“„ arXiv: 2509.15279v1</a>
  <a href="https://arxiv.org/pdf/2509.15279.pdf" class="toolbar-btn" target="_blank">ğŸ“¥ PDF</a>
  <button class="toolbar-btn favorite-btn" data-arxiv-id="2509.15279v1" data-paper-url="__CURRENT_PAGE__" onclick="toggleFavorite(this, '2509.15279v1', 'Fleming-R1: Toward Expert-Level Medical Reasoning via Reinforcement Learning')" title="æ·»åŠ åˆ°æ”¶è—å¤¹">â˜† æ”¶è—</button>
  <button class="toolbar-btn" onclick="copyLinkToClipboard(this)">ğŸ”— åˆ†äº«</button>
</div>


**ä½œè€…**: Chi Liu, Derek Li, Yan Shu, Robin Chen, Derek Duan, Teng Fang, Bryan Dai

**åˆ†ç±»**: cs.LG, cs.CL

**å‘å¸ƒæ—¥æœŸ**: 2025-09-18

---

## ğŸ’¡ ä¸€å¥è¯è¦ç‚¹

**Fleming-R1ï¼šé€šè¿‡å¼ºåŒ–å­¦ä¹ å®ç°ä¸“å®¶çº§åŒ»å­¦æ¨ç†**

ğŸ¯ **åŒ¹é…é¢†åŸŸ**: **æ”¯æŸ±äºŒï¼šRLç®—æ³•ä¸æ¶æ„ (RL & Architecture)** **æ”¯æŸ±ä¹ï¼šå…·èº«å¤§æ¨¡å‹ (Embodied Foundation Models)**

**å…³é”®è¯**: `åŒ»å­¦æ¨ç†` `å¼ºåŒ–å­¦ä¹ ` `çŸ¥è¯†å›¾è°±` `æ€ç»´é“¾` `ä¸´åºŠå†³ç­–æ”¯æŒ`

## ğŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. ç°æœ‰åŒ»å­¦AIæ¨¡å‹åœ¨ä¸´åºŠæ¨ç†ä¸­é¢ä¸´æŒ‘æˆ˜ï¼Œéœ€è¦å…¼é¡¾å‡†ç¡®æ€§å’Œæ¨ç†è¿‡ç¨‹çš„é€æ˜æ€§ã€‚
2. Fleming-R1é€šè¿‡RODSæ•°æ®ç­–ç•¥ã€CoTå†·å¯åŠ¨å’ŒRLVRæ¡†æ¶ï¼Œæå‡æ¨¡å‹çš„å¯éªŒè¯åŒ»å­¦æ¨ç†èƒ½åŠ›ã€‚
3. å®éªŒç»“æœè¡¨æ˜ï¼ŒFleming-R1åœ¨å¤šä¸ªåŒ»å­¦åŸºå‡†æµ‹è¯•ä¸­è¶…è¶Šäº†å¤§å‹åŸºçº¿æ¨¡å‹ï¼Œæ¥è¿‘GPT-4oçš„æ€§èƒ½ã€‚

## ğŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

å¤§å‹è¯­è¨€æ¨¡å‹åœ¨åŒ»å­¦åº”ç”¨ä¸­å±•ç°å‡ºæ½œåŠ›ï¼Œä½†ç”±äºéœ€è¦å‡†ç¡®çš„ç­”æ¡ˆå’Œé€æ˜çš„æ¨ç†è¿‡ç¨‹ï¼Œå®ç°ä¸“å®¶çº§ä¸´åºŠæ¨ç†ä»ç„¶å…·æœ‰æŒ‘æˆ˜æ€§ã€‚ä¸ºäº†è§£å†³è¿™ä¸ªé—®é¢˜ï¼Œæˆ‘ä»¬å¼•å…¥äº†Fleming-R1æ¨¡å‹ï¼Œè¯¥æ¨¡å‹é€šè¿‡ä¸‰ä¸ªäº’è¡¥çš„åˆ›æ–°è®¾è®¡æ¥å®ç°å¯éªŒè¯çš„åŒ»å­¦æ¨ç†ã€‚é¦–å…ˆï¼Œæˆ‘ä»¬çš„é¢å‘æ¨ç†çš„æ•°æ®ç­–ç•¥ï¼ˆRODSï¼‰ç»“åˆäº†ç²¾é€‰çš„åŒ»å­¦é—®ç­”æ•°æ®é›†å’ŒçŸ¥è¯†å›¾è°±å¼•å¯¼çš„åˆæˆæ•°æ®ï¼Œä»¥æé«˜å¯¹ä»£è¡¨æ€§ä¸è¶³çš„ç–¾ç—…ã€è¯ç‰©å’Œå¤šè·³æ¨ç†é“¾çš„è¦†ç›–ã€‚å…¶æ¬¡ï¼Œæˆ‘ä»¬é‡‡ç”¨æ€ç»´é“¾ï¼ˆCoTï¼‰å†·å¯åŠ¨æ¥ä»æ•™å¸ˆæ¨¡å‹ä¸­æç‚¼é«˜è´¨é‡çš„æ¨ç†è½¨è¿¹ï¼Œä»è€Œå»ºç«‹ç¨³å¥çš„æ¨ç†å…ˆéªŒã€‚ç¬¬ä¸‰ï¼Œæˆ‘ä»¬ä½¿ç”¨ç¾¤ä½“ç›¸å¯¹ç­–ç•¥ä¼˜åŒ–å®æ–½äº†ä¸€ä¸ªä¸¤é˜¶æ®µçš„å¯éªŒè¯å¥–åŠ±å¼ºåŒ–å­¦ä¹ ï¼ˆRLVRï¼‰æ¡†æ¶ï¼Œè¯¥æ¡†æ¶å·©å›ºäº†æ ¸å¿ƒæ¨ç†æŠ€èƒ½ï¼ŒåŒæ—¶é€šè¿‡è‡ªé€‚åº”ç¡¬æ ·æœ¬æŒ–æ˜æ¥é’ˆå¯¹æŒç»­å­˜åœ¨çš„å¤±è´¥æ¨¡å¼ã€‚åœ¨å„ç§åŒ»å­¦åŸºå‡†æµ‹è¯•ä¸­ï¼ŒFleming-R1æä¾›äº†æ˜¾è‘—çš„å‚æ•°é«˜æ•ˆæ”¹è¿›ï¼š7Bå˜ä½“è¶…è¿‡äº†æ›´å¤§çš„åŸºçº¿æ¨¡å‹ï¼Œè€Œ32Bæ¨¡å‹å®ç°äº†ä¸GPT-4oæ¥è¿‘çš„æ€§èƒ½ï¼Œå¹¶ä¸”å§‹ç»ˆä¼˜äºå¼ºå¤§çš„å¼€æºæ›¿ä»£æ–¹æ¡ˆã€‚è¿™äº›ç»“æœè¡¨æ˜ï¼Œç»“æ„åŒ–æ•°æ®è®¾è®¡ã€é¢å‘æ¨ç†çš„åˆå§‹åŒ–å’Œå¯éªŒè¯çš„å¼ºåŒ–å­¦ä¹ å¯ä»¥æ¨åŠ¨ä¸´åºŠæ¨ç†è¶…è¶Šç®€å•çš„å‡†ç¡®æ€§ä¼˜åŒ–ã€‚æˆ‘ä»¬å…¬å¼€å‘å¸ƒFleming-R1ï¼Œä»¥ä¿ƒè¿›åŒ»å­¦AIä¸­é€æ˜ã€å¯é‡å¤å’Œå¯å®¡è®¡çš„è¿›å±•ï¼Œä»è€Œåœ¨é«˜åº¦æ•æ„Ÿçš„ä¸´åºŠç¯å¢ƒä¸­å®ç°æ›´å®‰å…¨çš„éƒ¨ç½²ã€‚

## ğŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šç°æœ‰åŒ»å­¦AIæ¨¡å‹ï¼Œç‰¹åˆ«æ˜¯å¤§å‹è¯­è¨€æ¨¡å‹ï¼Œè™½ç„¶åœ¨åŒ»å­¦é—®ç­”æ–¹é¢å–å¾—è¿›å±•ï¼Œä½†ç¼ºä¹ä¸“å®¶çº§åˆ«çš„ä¸´åºŠæ¨ç†èƒ½åŠ›ã€‚ä¸»è¦ç—›ç‚¹åœ¨äºï¼š1ï¼‰å¯¹ç½•è§ç–¾ç—…ã€è¯ç‰©å’Œå¤æ‚æ¨ç†é“¾çš„è¦†ç›–ä¸è¶³ï¼›2ï¼‰æ¨ç†è¿‡ç¨‹ä¸é€æ˜ï¼Œéš¾ä»¥éªŒè¯ï¼›3ï¼‰éš¾ä»¥ä»é”™è¯¯ä¸­å­¦ä¹ ï¼ŒæŒç»­æ”¹è¿›ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šFleming-R1çš„æ ¸å¿ƒæ€è·¯æ˜¯é€šè¿‡ç»“æ„åŒ–çš„æ•°æ®è®¾è®¡ã€é¢å‘æ¨ç†çš„åˆå§‹åŒ–å’Œå¯éªŒè¯çš„å¼ºåŒ–å­¦ä¹ ï¼Œæå‡æ¨¡å‹çš„æ¨ç†èƒ½åŠ›å’Œé€æ˜åº¦ã€‚é€šè¿‡çŸ¥è¯†å›¾è°±å¢å¼ºæ•°æ®ï¼Œæ¨¡ä»¿ä¸“å®¶æ¨ç†è¿‡ç¨‹ï¼Œå¹¶åˆ©ç”¨å¼ºåŒ–å­¦ä¹ ä»å¯éªŒè¯çš„å¥–åŠ±ä¸­å­¦ä¹ ï¼Œä»è€Œå®ç°æ›´å¯é çš„ä¸´åºŠæ¨ç†ã€‚

**æŠ€æœ¯æ¡†æ¶**ï¼šFleming-R1çš„æŠ€æœ¯æ¡†æ¶åŒ…å«ä¸‰ä¸ªä¸»è¦éƒ¨åˆ†ï¼š1ï¼‰**é¢å‘æ¨ç†çš„æ•°æ®ç­–ç•¥ï¼ˆRODSï¼‰**ï¼šç»“åˆåŒ»å­¦QAæ•°æ®é›†å’ŒçŸ¥è¯†å›¾è°±ï¼Œç”Ÿæˆæ›´å…¨é¢çš„è®­ç»ƒæ•°æ®ã€‚2ï¼‰**æ€ç»´é“¾ï¼ˆCoTï¼‰å†·å¯åŠ¨**ï¼šä»æ•™å¸ˆæ¨¡å‹ä¸­æç‚¼é«˜è´¨é‡çš„æ¨ç†è½¨è¿¹ï¼Œä½œä¸ºæ¨¡å‹çš„åˆå§‹æ¨ç†èƒ½åŠ›ã€‚3ï¼‰**å¯éªŒè¯å¥–åŠ±å¼ºåŒ–å­¦ä¹ ï¼ˆRLVRï¼‰**ï¼šä½¿ç”¨ç¾¤ä½“ç›¸å¯¹ç­–ç•¥ä¼˜åŒ–ï¼Œé€šè¿‡å¯éªŒè¯çš„å¥–åŠ±ä¿¡å·ï¼Œå·©å›ºæ ¸å¿ƒæ¨ç†æŠ€èƒ½ï¼Œå¹¶é’ˆå¯¹å¤±è´¥æ¨¡å¼è¿›è¡Œä¼˜åŒ–ã€‚

**å…³é”®åˆ›æ–°**ï¼šFleming-R1çš„å…³é”®åˆ›æ–°åœ¨äºå…¶RLVRæ¡†æ¶ï¼Œè¯¥æ¡†æ¶ä½¿ç”¨å¯éªŒè¯çš„å¥–åŠ±ä¿¡å·ï¼Œè€Œéç®€å•çš„å‡†ç¡®ç‡ï¼Œæ¥è®­ç»ƒæ¨¡å‹ã€‚è¿™ç§æ–¹æ³•å…è®¸æ¨¡å‹å­¦ä¹ æ›´å¯é çš„æ¨ç†è¿‡ç¨‹ï¼Œå¹¶é’ˆå¯¹ç‰¹å®šçš„å¤±è´¥æ¨¡å¼è¿›è¡Œä¼˜åŒ–ã€‚æ­¤å¤–ï¼ŒRODSæ•°æ®ç­–ç•¥é€šè¿‡çŸ¥è¯†å›¾è°±å¢å¼ºæ•°æ®ï¼Œè§£å†³äº†ç½•è§ç—…ä¾‹å’Œå¤æ‚æ¨ç†é“¾çš„è¦†ç›–é—®é¢˜ã€‚

**å…³é”®è®¾è®¡**ï¼šRODSæ•°æ®ç­–ç•¥ä½¿ç”¨çŸ¥è¯†å›¾è°±æ¥è¯†åˆ«å’Œç”Ÿæˆç¼ºä¹ä»£è¡¨æ€§çš„ç–¾ç—…ã€è¯ç‰©å’Œæ¨ç†è·¯å¾„çš„åˆæˆæ•°æ®ã€‚CoTå†·å¯åŠ¨ä½¿ç”¨æ•™å¸ˆæ¨¡å‹ç”Ÿæˆé«˜è´¨é‡çš„æ¨ç†è½¨è¿¹ï¼Œå¹¶å°†å…¶ä½œä¸ºæ¨¡å‹çš„åˆå§‹æ¨ç†èƒ½åŠ›ã€‚RLVRæ¡†æ¶ä½¿ç”¨ç¾¤ä½“ç›¸å¯¹ç­–ç•¥ä¼˜åŒ–ï¼Œé€šè¿‡æ¯”è¾ƒä¸åŒæ¨ç†è·¯å¾„çš„å¥–åŠ±ï¼Œæ¥è®­ç»ƒæ¨¡å‹ã€‚å…·ä½“çš„å¥–åŠ±å‡½æ•°è®¾è®¡å’Œç¡¬æ ·æœ¬æŒ–æ˜ç­–ç•¥æ˜¯å½±å“æ¨¡å‹æ€§èƒ½çš„å…³é”®å› ç´ ï¼Œä½†è®ºæ–‡ä¸­æœªè¯¦ç»†è¯´æ˜å…·ä½“å‚æ•°è®¾ç½®ï¼Œå±äºæœªçŸ¥ã€‚

## ğŸ“Š å®éªŒäº®ç‚¹

Fleming-R1åœ¨å¤šä¸ªåŒ»å­¦åŸºå‡†æµ‹è¯•ä¸­è¡¨ç°å‡ºè‰²ã€‚7Bå˜ä½“è¶…è¶Šäº†æ›´å¤§çš„åŸºçº¿æ¨¡å‹ï¼Œè€Œ32Bæ¨¡å‹å®ç°äº†ä¸GPT-4oæ¥è¿‘çš„æ€§èƒ½ï¼Œå¹¶ä¸”å§‹ç»ˆä¼˜äºå¼ºå¤§çš„å¼€æºæ›¿ä»£æ–¹æ¡ˆã€‚è¿™äº›ç»“æœè¡¨æ˜ï¼Œé€šè¿‡ç»“æ„åŒ–æ•°æ®è®¾è®¡ã€é¢å‘æ¨ç†çš„åˆå§‹åŒ–å’Œå¯éªŒè¯çš„å¼ºåŒ–å­¦ä¹ ï¼Œå¯ä»¥æ˜¾è‘—æå‡åŒ»å­¦AIæ¨¡å‹çš„æ¨ç†èƒ½åŠ›ã€‚

## ğŸ¯ åº”ç”¨åœºæ™¯

Fleming-R1å…·æœ‰å¹¿æ³›çš„æ½œåœ¨åº”ç”¨é¢†åŸŸï¼ŒåŒ…æ‹¬è¾…åŠ©è¯Šæ–­ã€è¯ç‰©ç ”å‘ã€ä¸´åºŠå†³ç­–æ”¯æŒç­‰ã€‚é€šè¿‡æä¾›é€æ˜ã€å¯éªŒè¯çš„æ¨ç†è¿‡ç¨‹ï¼Œè¯¥æ¨¡å‹å¯ä»¥å¸®åŠ©åŒ»ç”Ÿåšå‡ºæ›´æ˜æ™ºçš„å†³ç­–ï¼Œæé«˜åŒ»ç–—è´¨é‡ï¼Œå¹¶é™ä½åŒ»ç–—é£é™©ã€‚æœªæ¥ï¼Œè¯¥æ¨¡å‹æœ‰æœ›æˆä¸ºåŒ»ç–—é¢†åŸŸçš„é‡è¦å·¥å…·ï¼Œä¿ƒè¿›åŒ»å­¦AIçš„è¿›æ­¥ã€‚

## ğŸ“„ æ‘˜è¦ï¼ˆåŸæ–‡ï¼‰

> While large language models show promise in medical applications, achieving expert-level clinical reasoning remains challenging due to the need for both accurate answers and transparent reasoning processes. To address this challenge, we introduce Fleming-R1, a model designed for verifiable medical reasoning through three complementary innovations. First, our Reasoning-Oriented Data Strategy (RODS) combines curated medical QA datasets with knowledge-graph-guided synthesis to improve coverage of underrepresented diseases, drugs, and multi-hop reasoning chains. Second, we employ Chain-of-Thought (CoT) cold start to distill high-quality reasoning trajectories from teacher models, establishing robust inference priors. Third, we implement a two-stage Reinforcement Learning from Verifiable Rewards (RLVR) framework using Group Relative Policy Optimization, which consolidates core reasoning skills while targeting persistent failure modes through adaptive hard-sample mining. Across diverse medical benchmarks, Fleming-R1 delivers substantial parameter-efficient improvements: the 7B variant surpasses much larger baselines, while the 32B model achieves near-parity with GPT-4o and consistently outperforms strong open-source alternatives. These results demonstrate that structured data design, reasoning-oriented initialization, and verifiable reinforcement learning can advance clinical reasoning beyond simple accuracy optimization. We release Fleming-R1 publicly to promote transparent, reproducible, and auditable progress in medical AI, enabling safer deployment in high-stakes clinical environments.

